MHB036C not checked
Minghui Pharmaceutical (Hangzhou) Ltd
FollowEvery change as it happens, and a Monday email
What this is
- How it works
- How it works isn't classified yet
- How it’s given
- “IV administration; Participants will continue treatment until the end of the study in the absence of unacceptable toxicities and confirmed disease progression.”In the company’s words, NCT07229599 on ClinicalTrials.gov
- Tested for
- Advanced Breast Cancer, Advanced Malignant Solid Tumor, Advanced Solid Tumor, Advanced Lung Cancer
- Main trialPhase 2
- “This is an open-label, multicenter Phase II study of MHB036C combined with MHB039A in patients with advanced Breast Cancer or other advanced malignant solid tumors. The study was designed to evaluate the safety, tolerability, pharmacokinetics (PK), and efficacy of MHB036C and MHB039A combination therapy.”In the company’s words, NCT07130383 on ClinicalTrials.gov
Other drugs for Advanced Breast Cancer
- D-0502InventisBio Co., Ltd · Phase 3
- ElacestrantStemline Therapeutics, Inc. · Phase 3
- YL202MediLink Therapeutics (Suzhou) Co., Ltd. · Phase 3
- SPH4336Shanghai Pharmaceuticals Holding Co., Ltd · Phase 2/3
- PembrolizumabMerck & Co. · Phase 3
- NiraparibGSK · Phase 3
Coming up3
- Apr 2027Phase 1/2 trial completes · ClinicalTrials.gov
- May 2029Phase 1/2 trial completes · ClinicalTrials.gov
- Aug 2029Phase 2 trial completes · ClinicalTrials.gov
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials4
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 2Recruiting | Aug 2029 | A Study of MHB036C Combined With MHB039A in Patients With Advanced Breast Cancer or Other Advanced Malignant Solid Tumors | |
| Phase 1/2Active, not recruiting | Apr 2027 | A Study of MHB036C for Advanced Solid Tumor | |
| Phase 1/2Recruiting | May 2029 | A Study of MHB036C Combined With Anti-tumor Therapies in Patients With Advanced Lung Cancer | |
| Phase 1/2Unknown | 31 Dec 2025 | Study of MHB036C in Participants With Advanced or Metastatic Solid Tumors |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026